| Company Name: |
T&W GROUP |
| Tel: |
021-61551611 13296011611 |
| Email: |
contact@trustwe.com |
9-(β-D-ribofuranosyl)-6-(furan-2-yl)purine manufacturers
|
| | 9-(β-D-ribofuranosyl)-6-(furan-2-yl)purine Basic information |
| Product Name: | 9-(β-D-ribofuranosyl)-6-(furan-2-yl)purine | | Synonyms: | 9-(β-D-ribofuranosyl)-6-(furan-2-yl)purine;6-(Furan-2-yl)purine-beta-D-riboside;6-(2-Furanyl)-9-beta-D-ribofuranosyl-9H-purine;9H-Purine, 6-(2-furanyl)-9-β-D-ribofuranosyl-;6-(Furan-2-yl)purine-β-D-riboside;6-(Furan-2-yl)purine-beta-D-riboside,9-(β-D-Ribofuranosyl)-6-(furan-2-yl)purine;(2R,3R,4S,5R)-2-(6-(furan-2-yl)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol;9-(beta-D-ribofuranosyl)-6-(furan-2-yl)purine | | CAS: | 352025-81-1 | | MF: | C14H14N4O5 | | MW: | 318.29 | | EINECS: | | | Product Categories: | | | Mol File: | 352025-81-1.mol |  |
| | 9-(β-D-ribofuranosyl)-6-(furan-2-yl)purine Chemical Properties |
| Melting point | 171-173 °C | | Boiling point | 656.982±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.832±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 13.114±0.70(predicted) |
| | 9-(β-D-ribofuranosyl)-6-(furan-2-yl)purine Usage And Synthesis |
| Uses | 6-(2-Furanyl)-9-β-D-ribofuranosyl-9H-purine is a purine nucleoside analogue. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 9-(β-D-ribofuranosyl)-6-(furan-2-yl)purine Preparation Products And Raw materials |
|